Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
MORESCO, M. N. dos S.
VIRGOLINO, H. de A.
MORAIS, M. P. E. de
MOTTA-PASSOS, I. da
ASSIS, L. M. S. de
AGUIAR, K. R. de L.
LOMBARDI, S. C. F.
MALHEIRO, A.
Citação
VOX SANGUINIS, v.107, n.1, p.19-25, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Brazil requires the performance of both a test for hepatitis B surface antigen (HBsAg) and a test for antibodies to the core of hepatitis B for blood donor screening. Blood centres in regions of high HBV endemicity struggle to maintain adequate stocks in face of the high discard rates due to anti-HBc reactivity. We evaluated the potential infectivity of donations positive for anti-HBc in search of a rational approach for the handling of these collections. Study Design and Methods We tested anti-HBc reactive blood donations from the state of Amazonas for the presence of HBV DNA and for titres of anti-HBs. The study population consists of village-based donors from the interior of Amazonas state. Results Among 3600 donations, 799 were anti-HBc reactive (22.2%). We were able to perform real-time PCR for the HBV S gene on specimens from 291 of these donors. Eight of these samples were negative for HBsAg and positive for HBV DNA and were defined as occult B virus infections (2.7%). Six of those eight specimens had anti-HBs titres above 100 mIU/ml, indicating the concomitant presence of the virus with high antibody titres. Conclusion A small proportion of anti-HBc reactive donors carry HBV DNA and anti-HBs testing is not useful for predicting viremia on them. This finding indicates the possibility of HBV transmission from asymptomatic donors, especially in areas of high HBV prevalence. Sensitive HBV DNA nucleic acid testing may provide another level of safety, allowing eventual use of anti-HBc reactive units in critical situations.
Palavras-chave
blood donors, Brazilian Amazon, HBV DNA, occult hepatitis B
Referências
  1. Allain JP, 2013, TRANSFUSION, V53, P1405, DOI 10.1111/trf.12096
  2. Arraes Luiz C., 2003, Revista do Instituto de Medicina Tropical de Sao Paulo, V45, P137, DOI 10.1590/S0036-46652003000300004
  3. Bertolini DA, 2012, INFECT GENET EVOL, V12, P1295, DOI 10.1016/j.meegid.2012.04.009
  4. Braga WSM, 2005, REV SOC BRAS MED TRO, V38, P218, DOI 10.1590/S0037-86822005000300002
  5. Braga WSM, 2012, REV SOC BRAS MED TRO, V45, P13, DOI 10.1590/S0037-86822012000100004
  6. Candotti D, 2009, J HEPATOL, V51, P798, DOI 10.1016/j.jhep.2009.05.020
  7. Castilho MD, 2012, AM J TROP MED HYG, V87, P768, DOI 10.4269/ajtmh.2012.12-0083
  8. Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024
  9. Ei Khouri M, 2010, ARQ GASTROENTEROL, V47, P35
  10. El-Zayadi AR, 2008, TRANSFUSION MED, V18, P55, DOI 10.1111/j.1365-3148.2007.00806.x
  11. Garson JA, 2005, J VIROL METHODS, V126, P207, DOI 10.1016/j.jviromet.2005.03.001
  12. Hanada D, 2011, VOX SANG S2, V101, P129
  13. Hanada D, 2011, VOX SANG, V101, P188
  14. IBGE - Instituto Brasileiro de Geografia e Estatistica, DAD CENS 2010 PUBL D
  15. Ismail AM, 2012, BLOOD TRANSFUS-ITALY, V10, P230, DOI 10.2450/2011.0046-11
  16. Levi José Eduardo, 2013, Rev Bras Hematol Hemoter, V35, P167, DOI 10.5581/1516-8484.20130039
  17. Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103
  18. Panigrahi R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-204
  19. Pereira LMMB, 2010, ESTUDO PREVALENCIA B
  20. Silva CMD, 2005, J INFECTION, V51, P24, DOI 10.1016/j.jinf.2004.07.007
  21. Stramer SL, 2011, NEW ENGL J MED, V36, P236
  22. SUSAM - Secretaria de Estado de Saude do Amazonas, 2010, MAP REG SAUD AM
  23. Tacke F, 2007, J CLIN VIROL, V38, P353, DOI 10.1016/j.jcv.2006.12.024
  24. Taira R, 2013, TRANSFUSION, V53, P1393, DOI 10.1111/j.1537-2995.2012.03909.x
  25. Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010
  26. Vermeulen M, 2009, TRANSFUSION, V49, P1115, DOI 10.1111/j.1537-2995.2009.02110.x
  27. Ximenes RAD, 2010, CAD SAUDE PUBLICA, V26, P1693, DOI 10.1590/S0102-311X2010000900003